CLINICAL_TRIALS
trial_result
· 2019-01-29
Clinical Trial Update: A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease [Phase 3]
Summary
A Phase 3 long-term active treatment study of Mongersen (GED-0301) for Crohn's disease was terminated, and results were posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED | Results posted: 2019-01-29